Same Drug Class

Pembrolizumab vs Trastuzumab

Pembrolizumab vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Pembrolizumab and Trastuzumab.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Pembrolizumab β€” 26 days; Trastuzumab β€” 28 days.

Chemical Properties

Type: Pembrolizumab β€” Antibody; Trastuzumab β€” Antibody.